{"id":13170,"date":"2021-09-11T11:35:40","date_gmt":"2021-09-11T11:35:40","guid":{"rendered":"https:\/\/haberglobal.com.tr\/dunya\/dso-turkiye-temsilcisi-batyr-berdyklychev-pandeminin-ne-zaman-sona-erecegine-dair-aciklama-yapti-131952"},"modified":"2021-09-11T11:35:40","modified_gmt":"2021-09-11T11:35:40","slug":"pandemi-ne-zaman-sona-erecek-dso-turkiye-temsilcisinden-aciklama","status":"publish","type":"post","link":"https:\/\/istanbulchannel.net\/index.php\/2021\/09\/11\/pandemi-ne-zaman-sona-erecek-dso-turkiye-temsilcisinden-aciklama\/","title":{"rendered":"Pandemi ne zaman sona erecek? DS\u00d6 T\u00fcrkiye temsilcisinden a\u00e7\u0131klama"},"content":{"rendered":"
<\/div>\n
<\/div>\n

Salg\u0131n\u0131n ne zaman bitece\u011fini kimsenin halen kesin olarak halen s\u00f6yleyemeyece\u011fini belirten Dr. Berdyklychev, “\u00c7\u00fcnk\u00fc yeni vakalar g\u00f6rmeye devam ediyoruz. Bu biraz da hem h\u00fck\u00fcmet d\u00fczeyinde, hem de bireysel d\u00fczeyde al\u0131nan \u00f6nlemlere ba\u011fl\u0131 olacak. En olumlu geli\u015fme Pazartesi g\u00fcn\u00fc itibariyle okullar\u0131n a\u00e7\u0131lmas\u0131 oldu. Hem DS\u00d6 hem de UNICEF bu karar\u0131 destekliyor” ifadesini kulland\u0131.<\/p>\n

Okullar\u0131n y\u00fcz y\u00fcze e\u011fitime ba\u015flamas\u0131yla beraber normalle\u015fmeye bir ad\u0131m daha yakla\u015fan T\u00fcrkiye’de a\u015f\u0131lanmada h\u0131zl\u0131 bir yol kat edilse de yeterli toplumsal ba\u011f\u0131\u015f\u0131kl\u0131k i\u00e7in hen\u00fcz istenen oranlara ula\u015f\u0131lamad\u0131. Okullar\u0131n a\u00e7\u0131lmas\u0131n\u0131n \u00e7ok \u00f6nemli ve olumlu bir geli\u015fme oldu\u011funu belirten D\u00fcnya Sa\u011fl\u0131k \u00d6rg\u00fct\u00fc T\u00fcrkiye Temsilcisi Dr. Batyr Berdyklychev, a\u015f\u0131laman\u0131n sosyal \u00f6nlemlerle birlikte vir\u00fcs\u00fc kontrol etmek ve pandemiyi durdurmak i\u00e7in bu a\u015famada elimizdeki en \u00f6nemli silah oldu\u011funu vurgulad\u0131. Ancak a\u015f\u0131lanma ile okullar\u0131n ve i\u015f yerlerinin a\u00e7\u0131k kalmaya devam edebilece\u011fini ve normale d\u00f6n\u00fc\u015f\u00fcn sa\u011flanabilece\u011fini s\u00f6yleyen Dr. Berdyklychev, rahatlamak i\u00e7in hen\u00fcz erken oldu\u011funu vurgulad\u0131.<\/p>\n

“SALGIN NE ZAMAN B\u0130TECEK, \u015eU AN K\u0130MSE S\u00d6YLEYEMEZ”<\/strong><\/p>\n

Salg\u0131n\u0131n ne zaman bitece\u011fini kimsenin halen kesin olarak halen s\u00f6yleyemeyece\u011fine dikkat \u00e7eken Dr. Berdyklychev, “\u00c7\u00fcnk\u00fc yeni vakalar g\u00f6rmeye devam ediyoruz. Bu biraz da hem h\u00fck\u00fcmet d\u00fczeyinde, hem de bireysel d\u00fczeyde al\u0131nan \u00f6nlemlere ba\u011fl\u0131 olacak. En olumlu geli\u015fme pazartesi g\u00fcn\u00fc itibariyle okullar\u0131n a\u00e7\u0131lmas\u0131 oldu. Hem DS\u00d6 hem de UNICEF bu karar\u0131 destekliyor. Okullar en son kapanan ve ilk a\u00e7\u0131lan yerler olmal\u0131” dedi ve okullar\u0131n a\u00e7\u0131lmas\u0131 ile beraber daha dikkatli olunmas\u0131 gerekti\u011fini, \u00f6zellikle temasl\u0131 izlemi ve sosyal \u00f6nlemler konusunun s\u0131k\u0131 tutulmas\u0131 gerekti\u011fini belirtti.<\/p>\n

“ANCAK A\u015eILAMA \u0130LE OKULLARIN VE \u0130\u015eYERLER\u0130N\u0130N A\u00c7IK KALMASI SA\u011eLANAB\u0130L\u0130R”<\/strong><\/p>\n

A\u015f\u0131laman\u0131n da bu \u00f6nlemlerle beraber h\u0131zla devam etmesi gerekti\u011fini belirten Dr. Berdyklychev, kimsenin tam kapanma d\u00f6nemlerini tekrar ya\u015famak istemedi\u011fini ama gerekirse yine baz\u0131 \u00f6nlemlerin al\u0131nmak zorunda kal\u0131nabilece\u011fini belirterek \u015funlar\u0131 s\u00f6yledi: “T\u00fcrkiye ba\u015f\u0131ndan beri a\u015f\u0131lama konusunda \u00f6rnek \u00fclkelerden birisi oldu. Hem iyi kaynak sa\u011flama hem de iyi grupland\u0131rma konusunda. Bildi\u011finiz gibi \u00f6ncelikle ya\u015fl\u0131lar ve sa\u011fl\u0131k \u00e7al\u0131\u015fanlar\u0131ndan ba\u015fland\u0131 ve \u015fu anda 12 ya\u015f\u0131n \u00fczerindeki kronik hastal\u0131\u011fa sahip \u00e7ocuklar da dahil olmak \u00fczere a\u015f\u0131lama t\u00fcm ya\u015f gruplar\u0131nda devam ediyor. Bu da hem okullar\u0131n a\u00e7\u0131k tutulmas\u0131 hem de ekonominin s\u00fcrd\u00fcr\u00fclmesine yard\u0131m edecek.”<\/p>\n

“KOV\u0130D A\u015eILARININ \u00dcCRETL\u0130 YAPILACA\u011eINI D\u00dc\u015e\u00dcNEM\u0130YORUM”<\/strong><\/p>\n

Pfizer-BioNTech a\u015f\u0131s\u0131n\u0131n FDA’dan tam ruhsat almas\u0131yla beraber d\u00fcnyada ruhsatland\u0131r\u0131lan ilk a\u015f\u0131 olmas\u0131yla beraber, “Ruhsat alan bir a\u015f\u0131n\u0131n art\u0131k ticari bir \u00fcr\u00fcn haline gelebilece\u011fi” y\u00f6n\u00fcndeki tart\u0131\u015fmalara da de\u011finen Dr. Berdyklychev, “Halen pandeminin ortas\u0131nday\u0131z. D\u00fcnya \u00fczerindeki hi\u00e7bir \u00fclkenin elimizdeki bu hayat kurtaran arac\u0131 paral\u0131 hale getirece\u011fini d\u00fc\u015f\u00fcnmek benim i\u00e7in \u00e7ok zor. Global a\u00e7\u0131dan duruma bakarsak, baz\u0131 d\u00fc\u015f\u00fck gelirli \u00fclkelerde a\u015f\u0131lanma oranlar\u0131n\u0131n \u00e7ok az oldu\u011funu g\u00f6r\u00fcyoruz. \u00d6rne\u011fin, Afrika \u00fclkelerinde n\u00fcfusunun y\u00fczde 1’inden daha az\u0131 a\u015f\u0131lanm\u0131\u015f durumda. Bu y\u00fczden DS\u00d6, i\u015fbirli\u011fi i\u00e7in Covax adl\u0131 bir giri\u015fim ba\u015flatt\u0131. B\u00f6ylece daha y\u00fcksek gelirli \u00fclkeler, daha d\u00fc\u015f\u00fck gelirli \u00fclkelere Covax giri\u015fimi \u00fczerinden a\u015f\u0131 ba\u011f\u0131\u015f\u0131nda bulunabiliyor. Y\u00fcksek a\u015f\u0131lama oranlar\u0131, zengin ya da fakir \u00fclke fark etmeksizin, d\u00fcnyan\u0131n her yerinde bu hastal\u0131ktan korunmak i\u00e7in tek yol” dedi.<\/p>\n

“DS\u00d6 L\u0130STES\u0130NDE OLAN A\u015eILARA SEYAHAT ENGEL\u0130 DO\u011eRU DE\u011e\u0130L”<\/strong><\/p>\n

DS\u00d6’n\u00fcn etkinlik, g\u00fcvenlik gibi belli kriterlere dayanarak verdi\u011fi Acil Kullan\u0131m Onay\u0131 alan a\u015f\u0131lar\u0131n say\u0131s\u0131 15’e ula\u015ft\u0131. Bu a\u015f\u0131lar\u0131n s\u0131k\u0131 bir s\u00fcre\u00e7ten ge\u00e7irilerek bu onay\u0131 alabildi\u011fine i\u015faret eden Dr. Berdyklychev, baz\u0131 \u00fclkelerin DS\u00d6 Acil Kullan\u0131m Listesi’nde bulundu\u011fu halde baz\u0131 a\u015f\u0131lar\u0131 seyahatlerde kabul etmemesini DS\u00d6’n\u00fcn prensip olarak onaylamad\u0131\u011f\u0131na da i\u015faret etti.<\/p>\n

“DS\u00d6 L\u0130STES\u0130NDEK\u0130 A\u015eILAR G\u00dcVENL\u0130 VE ETK\u0130L\u0130, SEYAHAT \u0130\u00c7\u0130N E\u015e\u0130T DAVRANILMALI”<\/strong><\/p>\n

Dr. Berdyklychev, DS\u00d6 listesinde bulunan t\u00fcm a\u015f\u0131lar\u0131n g\u00fcvenli ve etkili oldu\u011funu s\u00f6yleyerek “A\u015f\u0131lar\u0131n amac\u0131, hastaneye yat\u0131\u015flar\u0131, hastal\u0131\u011f\u0131n a\u011f\u0131rl\u0131\u011f\u0131n\u0131 ve \u00f6l\u00fcmleri azaltmak. DS\u00d6 Acil Kullan\u0131m Listesinde bulunan t\u00fcm a\u015f\u0131lar da bu konudaki belirli kriterleri kar\u015f\u0131lad\u0131klar\u0131 i\u00e7in bu listenin i\u00e7indeler. Burada iki farkl\u0131 konu var, birisi bilimsel kan\u0131tlarla sa\u011fl\u0131\u011f\u0131 daha fazla nas\u0131l koruyabiliriz, hastal\u0131\u011f\u0131n a\u011f\u0131rl\u0131\u011f\u0131n\u0131 nas\u0131l azaltabiliriz konusu. \u0130kincisi de tabii ki seyahat. Hangi a\u015f\u0131lar\u0131 tan\u0131yacaklar\u0131 konusunda Avrupa Birli\u011fi ve DS\u00d6 \u00fcye \u00fclkeleri, ba\u011f\u0131ms\u0131z karar verebilirler tabii ki. Ama DS\u00d6, a\u015f\u0131lanm\u0131\u015f olman\u0131n seyahat i\u00e7in bir \u00f6n gereklilik olmas\u0131n\u0131 \u00f6nermiyor. DS\u00d6’n\u00fcn acil kullan\u0131m listesindeki a\u015f\u0131lardan biriyle tam doz a\u015f\u0131lanm\u0131\u015f birine, hangi a\u015f\u0131y\u0131 olmu\u015f olursa olsun, (seyahat a\u00e7\u0131s\u0131ndan) e\u015fit davran\u0131lmas\u0131 gerekiyor. \u00c7\u00fcnk\u00fc bu a\u015f\u0131lar a\u011f\u0131r hastal\u0131k geli\u015fimine kar\u015f\u0131 etkili ve g\u00fcvenli. Ama s\u00f6ylemeliyim ki her \u00fclke, a\u015f\u0131 konusunda kendi yetkilerini, kendi kararlar\u0131n\u0131 almak konumunda. \u00c7\u00fcnk\u00fc her \u00fclke kendi ulusal d\u00fczenleme kurumunun kriterlerine dayanarak bu kararlar\u0131 al\u0131yor. DS\u00d6’n\u00fcn bu kararlara herhangi bir \u015fekilde m\u00fcdahil olmas\u0131 m\u00fcmk\u00fcn de\u011fil. Tabii ki a\u015f\u0131 onaylar\u0131 i\u00e7in \u00e7e\u015fitli uluslararas\u0131 kurumlarla birlikte \u00e7al\u0131\u015f\u0131yoruz ama bu konuda karar al\u0131c\u0131 mercii \u00fclkelerin kendi kurumlar\u0131” diye konu\u015ftu.<\/p>\n

“HERKESE 3. DOZ, K\u00dcRESEL G\u00dcVENL\u0130\u011e\u0130 ENGELLER”<\/strong><\/p>\n

D\u00fcnyada halen hen\u00fcz ilk dozunu dahi olamam\u0131\u015f milyarlarca insan varken baz\u0131 \u00fclkelerde ‘t\u00fcm n\u00fcfus i\u00e7in’ \u00fc\u00e7\u00fcnc\u00fc dozlara ba\u015flanacak olmas\u0131n\u0131 da pandemiye kar\u015f\u0131 ‘k\u00fcresel g\u00fcvenlik’ a\u00e7\u0131s\u0131ndan olumlu bulmad\u0131klar\u0131n\u0131 vurgulayan Dr. Berdyklychev, “\u0130ki doz a\u015f\u0131lamadan sonra ba\u011f\u0131\u015f\u0131kl\u0131k cevab\u0131n\u0131n ne zaman tam olarak d\u00fc\u015fece\u011fine dair bilimsel kan\u0131tlar hen\u00fcz tam olarak \u00f6n\u00fcm\u00fczde de\u011fil hala. Bu y\u00fczden DS\u00d6, \u00f6nceliklendirme yap\u0131lmas\u0131 \u00e7a\u011fr\u0131s\u0131nda bulunuyor. Baz\u0131 \u00fclkelerde a\u015f\u0131lanma oranlar\u0131 y\u00fczde 1 bile de\u011fil. Y\u00fcksek gelirli \u00fclkelerde ise 2 doz a\u015f\u0131lamada y\u00fcksek oranlara ula\u015f\u0131ld\u0131, \u015fimdi 3. doza ba\u015flamay\u0131 g\u00f6r\u00fc\u015fme halindeler. Burada k\u00fcresel a\u00e7\u0131dan sa\u011fl\u0131k g\u00fcvenli\u011fine bakmam\u0131z gerekiyor. \u00c7\u00fcnk\u00fc herkes a\u015f\u0131lanmad\u0131ktan sonra, vir\u00fcs ortadan kalkmayacak ve g\u00fcvenlik tehdidi devam edecek” dedi.<\/p>\n

“R\u0130SKL\u0130 GRUPLAR DI\u015eINDAK\u0130LERE 3. DOZA ERTELEME YAPILMALI”<\/strong><\/p>\n

DS\u00d6 Genel Merkezi’nin 3. doz konusundaki moratoryum (erteleme) \u00e7a\u011fr\u0131s\u0131na da de\u011finen Dr. Berdyklychev “3. dozlara eyl\u00fcl ay\u0131na kadar bir moratoryum uygulanmas\u0131 konusunda DS\u00d6’den \u00e7a\u011fr\u0131 yap\u0131ld\u0131. B\u00f6ylece eyl\u00fcl ay\u0131 itibariyle d\u00fcnya genelinde y\u00fczde 10 a\u015f\u0131lama oran\u0131na ula\u015f\u0131lmas\u0131 hedefleniyor. 2022’nin ortalar\u0131na do\u011fru da k\u00fcresel \u00e7apta y\u00fczde 70 a\u015f\u0131lanma oranlar\u0131na ula\u015f\u0131lmas\u0131 hedefleniyor. DS\u00d6 Avrupa Direkt\u00f6r\u00fc Hans Kluge’nin s\u00f6zlerini yinelemek istiyorum burada. 3. doz halihaz\u0131rda, sa\u011fl\u0131kl\u0131 olan insanlar i\u00e7in bir ekstra doz olarak kullan\u0131lmamal\u0131. Tabii ki, belli bir zaman sonras\u0131nda ba\u011f\u0131\u015f\u0131kl\u0131k cevap d\u00fc\u015fecek, antikor d\u00fczeyi azalacak ama 3. dozu \u015fu an daha korunmas\u0131z, risk grubu n\u00fcfusa ay\u0131rmal\u0131y\u0131z. Ba\u011f\u0131\u015f\u0131kl\u0131\u011f\u0131 bask\u0131lanm\u0131\u015f ki\u015filer ya da iki doz a\u015f\u0131dan sonra beklenen imm\u00fcn yan\u0131t olu\u015fmayan risk grubu hastalar, tabii ki bu moratoryumu karar\u0131n\u0131n d\u0131\u015f\u0131nda tutulmal\u0131. Milyarlarca insan ilk dozunu bile alamam\u0131\u015f durumda. \u00d6ncelikli hedefimiz, birinci ve ikinci dozlar\u0131 tamamlamak olmal\u0131” diyerek s\u00f6zlerini noktalad\u0131.<\/p>\n

Kaynak: Haber Global<\/p>\n","protected":false},"excerpt":{"rendered":"

<p>Salg\u0131n\u0131n ne zaman bitece\u011fini kimsenin halen kesin olarak halen s\u00f6yleyemeyece\u011fini belirten Dr. Berdyklychev, "\u00c7\u00fcnk\u00fc yeni vakalar g\u00f6rmeye devam ediyoruz. Bu biraz…<\/p>\n","protected":false},"author":2,"featured_media":13171,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[9],"tags":[],"class_list":["post-13170","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-dunya"],"_links":{"self":[{"href":"https:\/\/istanbulchannel.net\/index.php\/wp-json\/wp\/v2\/posts\/13170","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/istanbulchannel.net\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/istanbulchannel.net\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/istanbulchannel.net\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/istanbulchannel.net\/index.php\/wp-json\/wp\/v2\/comments?post=13170"}],"version-history":[{"count":0,"href":"https:\/\/istanbulchannel.net\/index.php\/wp-json\/wp\/v2\/posts\/13170\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/istanbulchannel.net\/index.php\/wp-json\/wp\/v2\/media\/13171"}],"wp:attachment":[{"href":"https:\/\/istanbulchannel.net\/index.php\/wp-json\/wp\/v2\/media?parent=13170"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/istanbulchannel.net\/index.php\/wp-json\/wp\/v2\/categories?post=13170"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/istanbulchannel.net\/index.php\/wp-json\/wp\/v2\/tags?post=13170"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}